We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 6
Most popular |Most recent

2015 年以来中国医药健康领域动态回顾

China - March 29 2016 在 2015 年至今将近一年的时间内中国的医药健康领域见证了密集出台的一系列新政策和新法 规不管是政策制定者还是行业从业人员都经历了一个异常忙碌甚至可以说是疲于奔...


China - March 1 2016 2016年2月25日国务院法制办公布了中华人民共和国反不正当竞争法修订草案送审稿“修订草案”实施23年的现行中华人民共和国反不正当竞争法“...

David Tang.

Interpreting the Revised Draft of the Anti-unfair Competition Law: Commercial Bribery

China - March 1 2016 On February 25, 2016, the Legislative Affairs Office of the State Council promulgated the Anti-Unfair Competition Law of the People’s Republic of...

David Tang.

Pros and Cons of Drug Price Renegotiation

China - December 31 2015 The issue of second-round drug price negotiations following centralized procurement ("Price Renegotiation") was bound to be controversial from the...

David Tang, Yan WANG, Chen Ma, Will HUANG.

Legal Analysis of Illegal Pharmaceutical and Medical Device Advertising under the New Advertising Law

China - December 31 2015 The pharmaceutical, medical device, and food (including health food) industries have always been particularly prone to illegal advertising. Since...

Chao Wang.